Welcome to the Vaccine Clinical Trials Program
Sealy Institute for Vaccine Sciences (SIVS) Clinical Trials Program has
been in existence since 2002. Our investigators, research nurses and
coordinators are experienced in all phases of vaccine clinical trials
from first-in-human phase I studies through Phase IV post-marketing
studies. Study populations have included premature infants, infants and
toddlers, children, adolescents, adults and the elderly.
trials are the final step in the vaccine development process. The
purpose of the SIVS Clinical Trials Program is to perform these clinical
trials, providing the necessary data on vaccine efficacy,
immunogenicity and safety in humans.